Boehringer Ingelheim Cattle Health
Published on Mon, 10/12/2009 - 3:53pm
Boehringer Ingelheim Animal Health Enters into Agreement to Acquire Certain Assets of Fort Dodge Animal Health from Pfizer Acquisition will strengthen Boehringer Ingelheim’s position as a vaccine supplier among the world’s top animal health companies. Ingelheim, Germany and St. Joseph, MO (September 21, 2009) – Boehringer Ingelheim, a global pharmaceutical group of companies, together with its U.S. animal health business Boehringer Ingelheim Vetmedica, Inc., announced today that it has entered into an agreement with Pfizer to acquire certain assets of Wyeth Pharmaceutical’s Fort Dodge Animal Health business upon the closing of the global Pfizer-Wyeth merger, which is expected to occur early in the fourth quarter. The deal, which is subject to anti-trust clearance, significantly increases the size of Boehringer Ingelheim’s companion animal and cattle portfolios.